SCHEMBL18796089

SCHEMBL18796089

Cc1nc2c(F)c(F)ccc2nc1Oc1cc(Cl)ccc1Br

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 5/20 0.34
PDE2A O00408 4/20 0.33
PDE10A Q9Y233 3/20 0.33
MAPT P10636 4/20 0.32
NPC1 O15118 1/20 0.32
EPAS1 Q99814 2/20 0.32
KDM4E B2RXH2 3/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 2/20 0.32
CHEK1 O14757 2/20 0.32
RAB9A P51151 1/20 0.31
PRNP P04156 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
USP2 O75604 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HTR2A P28223 1/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18795995 0.90 L3MBTL1 (0.38) AMY1APDE2APDE10AMAPTNPC1
SCHEMBL18796315 0.89 AMY1A (0.35) AMY1APDE2APDE10A
SCHEMBL18796200 0.89 KMT2A (0.33) KMT2A
SCHEMBL20551125 0.84 GCK (0.31) KDM4EHPGD
SCHEMBL18795930 0.83 LMNA (0.34) PDE2APDE10A
SCHEMBL18796223 0.83 LCK (0.40) MAPTNPC1KDM4EMEN1KMT2A
SCHEMBL20551188 0.83 KDM4E (0.30) KDM4EHPGD
SCHEMBL18796202 0.81 LYN (0.37) AMY1AMAPTEPAS1
SCHEMBL18795994 0.81 MAPT (0.34) MAPTNPC1KDM4EMEN1KMT2A
SCHEMBL20552245 0.81 LMNA (0.32) AMY1AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT AMY1A 4184/4885PDE2A 364/4885PDE10A 798/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT AMY1A 4184/4885PDE2A 364/4885PDE10A 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.